Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Cancers
|
July 14, 2023
Disease Perception Is Correlated with Health-Related Quality of Life in Patients Suffering from Myelodysplastic Syndromes: Results of the Belgian Be-QUALMS Study
Bert Heyrman, Stef Meers, Ann De Becker, et al.
Clinical Hematology International
|
October 13, 2022
Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study
Ann Janssens, Zwi N Berneman, Fritz Offner, et al.
Ejhaem
|
October 17, 2024
Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives
Bert Heyrman, Stef Meers, Sélim Sid, et al.
Bone Marrow Transplantation
|
February 6, 2025
Life 2.0: a comprehensive cross-sectional profiling of long-term allogeneic hematopoietic cell transplantation survivors compared to a matched general population cohort
Hélène Schoemans, Kathy Goris, Steffen Fieuws, et al.
Annals of Hematology
|
May 4, 2021
Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry
Timothy Devos, Violaine Havelange, Koen Theunissen, et al.
The Lancet. Haematology
|
December 8, 2023
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
Amer M Zeidan, Kiyoshi Ando, Odile Rauzy, et al.
Hematology (Amsterdam, Netherlands)
|
August 14, 2025
Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib - final 6-year results from a Belgian registry
Timothy Devos, Dries Deeren, Koen Theunissen, et al.
Journal of Geriatric Oncology
|
August 10, 2025
Prospective comparison between geriatric assessment and clinical evaluation in 200 newly diagnosed older adults with multiple myeloma
Jolien Raddoux, Cindy Kenis, Anneleen Vanhellemont, et al.
Acta Clinica Belgica
|
February 23, 2017
Results from the Belgian mantle cell lymphoma registry
Vibeke Vergote, Ann Janssens, Marc André, et al.
Hemasphere
|
October 31, 2022
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
Jon Salmanton-García, Francesco Marchesi, Andreas Glenthøj, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Cancers
|
July 14, 2023
Disease Perception Is Correlated with Health-Related Quality of Life in Patients Suffering from Myelodysplastic Syndromes: Results of the Belgian Be-QUALMS Study
Bert Heyrman, Stef Meers, Ann De Becker, et al.
Clinical Hematology International
|
October 13, 2022
Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study
Ann Janssens, Zwi N Berneman, Fritz Offner, et al.
Ejhaem
|
October 17, 2024
Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives
Bert Heyrman, Stef Meers, Sélim Sid, et al.
Bone Marrow Transplantation
|
February 6, 2025
Life 2.0: a comprehensive cross-sectional profiling of long-term allogeneic hematopoietic cell transplantation survivors compared to a matched general population cohort
Hélène Schoemans, Kathy Goris, Steffen Fieuws, et al.
Annals of Hematology
|
May 4, 2021
Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry
Timothy Devos, Violaine Havelange, Koen Theunissen, et al.
The Lancet. Haematology
|
December 8, 2023
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
Amer M Zeidan, Kiyoshi Ando, Odile Rauzy, et al.
Hematology (Amsterdam, Netherlands)
|
August 14, 2025
Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib - final 6-year results from a Belgian registry
Timothy Devos, Dries Deeren, Koen Theunissen, et al.
Journal of Geriatric Oncology
|
August 10, 2025
Prospective comparison between geriatric assessment and clinical evaluation in 200 newly diagnosed older adults with multiple myeloma
Jolien Raddoux, Cindy Kenis, Anneleen Vanhellemont, et al.
Acta Clinica Belgica
|
February 23, 2017
Results from the Belgian mantle cell lymphoma registry
Vibeke Vergote, Ann Janssens, Marc André, et al.
Hemasphere
|
October 31, 2022
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
Jon Salmanton-García, Francesco Marchesi, Andreas Glenthøj, et al.
Page
of 4